CDER Dispute Resolution Policy Will Test “Ad Hoc” Arbitration
Executive Summary
FDA's Center for Drug Evaluation & Research will run a one-year test of a formal dispute resolution process to resolve differences of opinion among reviewers
You may also be interested in...
CDER “Equal Voice” Policy Does Not Mean Equal Weight In Decision-Making
The Center for Drug Evaluation and Research’s new internal guidelines implementing the “Equal Voice” initiative suggest each scientific discipline’s perspective will be given equal time, but not equal weight.
CDER “Equal Voice” Policy Does Not Mean Equal Weight In Decision-Making
The Center for Drug Evaluation and Research’s new internal guidelines implementing the “Equal Voice” initiative suggest each scientific discipline’s perspective will be given equal time, but not equal weight.
FDA Scientists Fear Retaliation For Conveying Health Risks, Survey Finds
FDA scientists fear retaliation for expressing health concerns to the public, according to results of a Union of Concerned Scientists survey released July 20